Skip to main content
ExpreS2ion Biotech Holding AB logo

ExpreS2ion Biotech Holding AB — Investor Relations & Filings

Ticker · EXPRS2 ISIN · SE0023261292 LEI · 549300FJK50P1ORYJC45 ST Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country SE Sweden
Listing ST EXPRS2

About ExpreS2ion Biotech Holding AB

https://www.expres2ionbio.com/

ExpreS2ion Biotech Holding AB is a clinical-stage biotechnology company that develops innovative vaccines and biologics to address unmet medical needs. The company utilizes its proprietary protein expression platform, ExpreS2, to create a pipeline of vaccine candidates. Its development portfolio focuses on both therapeutic cancer vaccines (immunotherapies) and prophylactic vaccines for major infectious diseases, including malaria and breast cancer. ExpreS2ion advances its programs through strategic collaborations and licensing agreements with partners, such as the Serum Institute of India for its novel blood-stage malaria vaccine.

Recent filings

No filings indexed yet

We are still gathering filings for ExpreS2ion Biotech Holding AB. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.